Ping An Biomedical Co., Ltd. (PASW)
NASDAQ: PASW · Real-Time Price · USD
0.146
-0.009 (-5.61%)
Mar 5, 2026, 4:00 PM EST - Market closed
Ping An Biomedical Income Statement
Financials in millions CNY. Fiscal year is October - September.
Millions CNY. Fiscal year is Oct - Sep.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 |
| Revenue | 34.15 | 87.62 | 82.56 | 114.55 | 99.52 | Upgrade
|
| Revenue Growth (YoY) | -61.03% | 6.13% | -27.92% | 15.10% | 79.43% | Upgrade
|
| Cost of Revenue | 33.2 | 82.21 | 78.32 | 100.4 | 85.25 | Upgrade
|
| Gross Profit | 0.95 | 5.42 | 4.24 | 14.14 | 14.27 | Upgrade
|
| Selling, General & Admin | 6.31 | 5.3 | 3.6 | 3.52 | 3.76 | Upgrade
|
| Operating Expenses | 15.65 | 5.42 | 3.63 | 3.33 | 6 | Upgrade
|
| Operating Income | -14.7 | -0 | 0.61 | 10.82 | 8.27 | Upgrade
|
| Interest Expense | -0.31 | -0.71 | -1.74 | -1.57 | -1.36 | Upgrade
|
| Interest & Investment Income | 0.33 | 0 | 0.16 | 0.04 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.01 | - | -0 | 0.19 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | 0.03 | 1.01 | 0.34 | 0.72 | Upgrade
|
| Pretax Income | -14.68 | -0.68 | 0.04 | 9.63 | 7.82 | Upgrade
|
| Income Tax Expense | -1.86 | 0.6 | 1.04 | 2.4 | 2.61 | Upgrade
|
| Net Income | -12.83 | -1.28 | -0.99 | 7.23 | 5.21 | Upgrade
|
| Net Income to Common | -12.83 | -1.28 | -0.99 | 7.23 | 5.21 | Upgrade
|
| Net Income Growth | - | - | - | 38.61% | 170.96% | Upgrade
|
| Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 | Upgrade
|
| Shares Change (YoY) | 2.66% | - | - | - | - | Upgrade
|
| EPS (Basic) | -0.69 | -0.07 | -0.06 | 0.40 | 0.29 | Upgrade
|
| EPS (Diluted) | -0.69 | -0.07 | -0.06 | 0.40 | 0.29 | Upgrade
|
| EPS Growth | - | - | - | 38.61% | 170.96% | Upgrade
|
| Free Cash Flow | -6.43 | 14.63 | -6.08 | 21.06 | -31.4 | Upgrade
|
| Free Cash Flow Per Share | -0.35 | 0.81 | -0.34 | 1.17 | -1.74 | Upgrade
|
| Gross Margin | 2.78% | 6.18% | 5.14% | 12.35% | 14.34% | Upgrade
|
| Operating Margin | -43.05% | -0.00% | 0.74% | 9.44% | 8.31% | Upgrade
|
| Profit Margin | -37.57% | -1.47% | -1.20% | 6.31% | 5.24% | Upgrade
|
| Free Cash Flow Margin | -18.82% | 16.70% | -7.37% | 18.39% | -31.55% | Upgrade
|
| EBITDA | -14.7 | 0.01 | 0.65 | 10.84 | 8.29 | Upgrade
|
| EBITDA Margin | -43.04% | 0.01% | 0.78% | 9.46% | 8.33% | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.03 | 0.02 | 0.02 | Upgrade
|
| EBIT | -14.7 | -0 | 0.61 | 10.82 | 8.27 | Upgrade
|
| EBIT Margin | -43.05% | -0.00% | 0.74% | 9.44% | 8.31% | Upgrade
|
| Effective Tax Rate | - | - | 2484.34% | 24.92% | 33.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.